Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Toth, K.; | Nemes, J. | Czopf, L. | Kapronczay, P. | Kesmarky, G. | Juricskay, I.
Affiliations: 1st Department of Medicine, Division of Cardiology, University Medical School of Pecs, Hungary | 1st Department of Medicine, Division of Endocrinology, University Medical School of Pecs, Hungary
Note: [] Address for correspondence: Kalman Toth, M.D., Ph.D., 1st Department of Medicine, Division of Cardiology, University Medical School of Pecs, 7643 Pecs, Ifjusag u. 13, Hungary. Tel.: +36 72 324 122/1781; Fax: +36 72 325 723; E‐mail: TothK@clinics.pote.hu.
Abstract: It is known from previous studies that hemorheological parameters are altered in patients with essential hypertension. The hemorheological and hemodynamical effects of doxazosin, a selective alpha‐1‐adrenoreceptor blocker agent, was examined in twenty patients (mean age: 54 \pm 10 years) with essential hypertension. Hemorheologic (hematocrit, fibrinogen, plasma and whole blood viscosity) and hemodynamic (cardiac output and index, total peripheral resistance) parameters and plasma lipids were determined. The measurements were carried out before the beginning of the treatment, after 1 week and after 12 weeks treatment periods. Besides significant reduction of blood pressure and total peripheral resistance (p<0.001), a decrease in cholesterol (p <0.001) and triglyceride (p<0.01) levels and a beneficial effect on hemorheological parameters was detected. Fibrinogen and plasma viscosity decreased significantly (p <0.01). Hematocrit value was also lower after one week (p<0.001), then an increase could be seen. Whole blood viscosity showed similar changes as hematocrit, but the degree of its final increase was slighter, which was supported by the significantly lower value of corrected blood viscosity (p <0.05).
Keywords: Essential hypertension, blood rheology, plasma lipids, doxazosin
Journal: Clinical Hemorheology and Microcirculation, vol. 20, no. 1, pp. 57-61, 1999
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
sales@iospress.com
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
info@iospress.nl
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office info@iospress.nl
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
china@iospress.cn
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
如果您在出版方面需要帮助或有任何建, 件至: editorial@iospress.nl